Sai Life Sciences Allotment Status : Check Online on NSE, BSE and KFin Technologies
The IPO of Sai Life Sciences, a company specializing in the research, development, and production of small-molecule new chemical entities, was open for subscription from December 11, 2024, to December 13, 2024. The allotment of shares is likely to happen today, December 16, 2024, and the shares are tentatively scheduled to be listed on the BSE and NSE on December 18, 2024.
Sai Life Sciences IPO Details
The Sai Life Sciences IPO is a book-built issue worth ₹3,042.62 crores, comprising a fresh issue of 1.73 crore shares aggregating ₹950.00 crores and an offer for sale of 3.81 crore shares amounting to ₹2,092.62 crores. The IPO, with a price band of ₹522 to ₹549 per share, was open for subscription from December 11, 2024, to December 13, 2024. The basis of allotment is expected to be finalized today. Shares of Sai Life Sciences are tentatively scheduled to be listed on the BSE and NSE on December 18, 2024.
Checking the Sai Life Sciences Allotment Status
Steps to Check Allotment Status on BSE
- Visit the BSE website here.
- Under "Issue Type", select "Equity".
- From the "Issue Name" dropdown menu, choose "Sai Life Sciences Limited".
- Enter your application number.
- Provide your PAN card ID.
- Click on 'I am not a robot' and then click the "Search" button.
Steps to Check Allotment Status on NSE
- Go to the IPO allotment page of NSE, here.
- New users need to sign up, while registered users can log in.
- Enter the required details, like your application number or PAN.
- Click on the "Get Data" button.
Steps to Check Allotment Status on Kfin Technologies India
- Visit the IPO registrar’s website here.
- Choose 'Vishal Mega Mart Limited' from the Select IPO dropdown menu.
- Select either Application No., Demat Account, or PAN.
- Enter the details as per the option selected.
- Enter the Captcha code and click on Submit. Your Vishal Mega Mart IPO allotment status will be displayed on the screen.
Sai Life Sciences Business Overview
Founded in January 1999, Sai Life Sciences Limited focuses on the research, development, and production of small-molecule new chemical entities. The company delivers tailored solutions to biotech firms and global pharmaceutical companies.
In the financial year 2024 and as of September 30, 2024, Sai Life Sciences catered to over 280 pharmaceutical innovators, including more than 230 during September alone. Significantly, the company partnered with 18 of the top 25 pharmaceutical companies globally by revenue in the calendar year 2023. Its services span major markets such as the United States, the United Kingdom, Europe, and Japan.
Sai Life Sciences IPO Day 3 Subscription Status
(December 13, 2024, End of Day)
On the third day of bidding, the MobiKwik IPO achieved a subscription rate of 10.27 times the total shares on offer.
- The Non-Institutional Investors (NIIs) showed significant interest, subscribing 4.99 times their designated quota.
- The Retail Investors segment also garnered exceptional participation, with subscriptions soaring to 1.39 times their allocation.
- Meanwhile, the Qualified Institutional Buyers (QIBs) recorded a subscription level of 29.78 times.
Utilization of IPO Proceeds
The company plans to utilize the Net Proceeds for two primary objectives:
- To repay or prepay, in full or in part, certain outstanding borrowings
- To fund general corporate purposes.